Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc. buy Needham & Company LLC

Start price
€192.85
24.04.24 / 50%
Target price
€275.07
24.04.25
Performance (%)
4.80%
Price
€202.10
03.05.24
Summary
This prediction is currently active. With a performance of 4.80%, the BUY prediction by Needham___Company_LL for Biogen Inc. is trending in the right direction. This prediction currently runs until 24.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this prediction
Performance without dividends (%)
Name 1w
Biogen Inc. 3.482%
iShares Core DAX® -0.922%
iShares Nasdaq 100 0.371%
iShares Nikkei 225® 2.224%
iShares S&P 500 -0.026%

Comments by Needham___Company_LL for this prediction

In the thread Biogen Inc. diskutieren
Prediction Buy
Perf. (%) 4.80%
Target price 275.066
Change
Ends at 24.04.25

Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat

Stopped prediction by Needham___Company_LL for Biogen Inc.

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€220.60
13.02.24
€284.87
13.02.25
-8.39%
03.05.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€229.60
26.10.23
€289.60
26.10.24
-11.98%
03.05.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€247.60
08.08.23
€278.65
08.08.24
-18.38%
03.05.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€242.80
25.07.23
€290.08
25.07.24
-16.76%
03.05.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€257.80
11.04.23
€297.70
11.04.24
-26.01%
12.04.24